PTC Therapeutics, Inc. SEC filings PTCT

PTC Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 5, 2017. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

PTC Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 13, 2026 Oct 9, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
144 Notice of proposed sale Oct 9, 2026 —
4 Insider transaction Oct 7, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 7, 2026 —
144 Notice of proposed sale Oct 6, 2026 —
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 2, 2026 Sep 30, 2026
144 Notice of proposed sale Sep 30, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 21, 2026 Sep 21, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 11, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 9, 2026 —
4 Insider transaction Aug 28, 2026 Aug 26, 2026
8-K Current report
Material agreement
Aug 28, 2026 Aug 25, 2026
144/A Filing Aug 25, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Aug 13, 2026 Aug 12, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
144 Notice of proposed sale Aug 4, 2026 —
4 Insider transaction Jul 30, 2026 Jul 28, 2026
3 Initial insider ownership Jul 30, 2026 Jul 28, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
144 Notice of proposed sale Jul 14, 2026 —
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
144 Notice of proposed sale Jun 22, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 18, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
8-K Current report
Other events
Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 10, 2026 —
8-K Current report
Officer or director change
Jun 9, 2026 Jun 8, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 2, 2026
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
144 Notice of proposed sale May 14, 2026 —
144 Notice of proposed sale May 14, 2026 —
4 Insider transaction May 12, 2026 May 8, 2026
144 Notice of proposed sale May 8, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
8-K Current report
Regulation FD disclosure
Apr 28, 2026 Apr 28, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 21, 2026 —
ARS Annual report to shareholders Apr 20, 2026 Jan 31, 2026
DEFA14A Additional proxy material Apr 20, 2026 —
DEF 14A Proxy statement Apr 20, 2026 Jun 2, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 26, 2026 Mar 24, 2026
3 Initial insider ownership Mar 26, 2026 Mar 24, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 25, 2026 Mar 24, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 12, 2026 —
144 Notice of proposed sale Mar 10, 2026 —
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Regulation FD disclosure
Feb 12, 2026 Feb 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Jan 2, 2026 Dec 30, 2025
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Dec 30, 2025 —
8-K Current report
Material agreement
Dec 29, 2025 Dec 29, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 19, 2025 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 18, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 5, 2025 Dec 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 4, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
Large accelerated filer
SEC CIK
1070081
Former names
PTC THERAPEUTICS INC (until Oct 12, 2005)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.